Ledger.Open graph →
SEC Form D · filed September 4, 2024

Arsenal Biosciences, Inc

Offering
$325.4M
Sold
$325.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Beth Seidenberg · South San Francisco, CADirectorBrook Byers · South San Francisco, CADirectorMatthew Fust · South San Francisco, CADirectorKenneth Drazan · South San Francisco, CAExec · DirectorValentin Barsan · South San Francisco, CADirectorSean Parker · South San Francisco, CADirectorJames Ahlers · Boston, MAExecJeffrey F. O'Donnell Sr · Malvern, PADirectorJeffrey F. O'Donnell Jr · Malvern, PADirectorWilliam A. Rupp · Old Bethpage, NYExec · DirectorJon C. Northrop · Old Bethpage, NYDirectorMark A. Smith · Old Bethpage, NYDirectorEdward A. Schafer · Old Bethpage, NYDirectorIrene Pleasure · South San Francisco, CAExecNeeraj B. Hablani · New York, NYDirectorRaghav Mecheri · New York, NYExec · DirectorJames B. Bollas · New York, NYDirectorAndrew J. Secrist · Salt Lake City, UTDirectorSarah Hunt · Purchase, NYDirectorJennifer L. Norris · Denver, CODirectorJames Ahlers · Boston, MAExecIrene Pleasure · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗